Octavio Espinoza

LGND

Octavio Espinoza serves as officer: Chief Financial Officer at Ligand Pharmaceuticals Incorporated (LGND). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

2 trades

$312.2K

Total Sells

13 trades

$9.45M

Net Position

Net Seller

$9.14M

Companies Traded

LGND, LGNZZ, LGNDZ

Active Period

Nov 2022 – Mar 2026

15 total trades

Most Recent

Sell LGND

Mar 13, 2026 · $687.8K

Octavio Espinoza's Insider Trading at Ligand Pharmaceuticals Incorporated (LGND)

Buys

1 · $156.1K

Sells

9 · $6.03M

Total Shares Bought

1,500

Total Shares Sold

41,792

LGND Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Mar 13, 2026	Sell	3,057	$225.00	$687.8K	21,010
Mar 6, 2026	Sell	13,423	$205.83	$2.76M	34,386
Dec 16, 2025	Sell	1,804	$188.31	$339.7K	26,186
May 13, 2025	Buy	1,500	$104.06	$156.1K	27,932
Mar 6, 2025	Sell	5,000	$115.03	$575.1K	18,879
Dec 26, 2024	Sell	2,104	$116.37	$244.8K	20,647
Sep 24, 2024	Sell	1,275	$103.94	$132.5K	25,685
May 17, 2024	Sell	13,293	$86.26	$1.15M	23,882
Feb 29, 2024	Sell	140	$88.46	$12.4K	29,755
Nov 10, 2022	Sell	1,696	$75.64	$128.3K	8,857

Octavio Espinoza's Insider Trading at LIGAND PHARMS BETA CVR (LGNZZ)

Buys

0 · $0.00

Sells

1 · $2.16M

Total Shares Bought

Total Shares Sold

11,763

LGNZZ Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Feb 14, 2026	Sell	11,763	$183.83	$2.16M	0

Octavio Espinoza's Insider Trading at LIGAND PHARMS INC CVR (LGNDZ)

Buys

1 · $156.1K

Sells

3 · $1.26M

Total Shares Bought

1,500

Total Shares Sold

8,666

LGNDZ Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value
Dec 12, 2025	Sell	1,804	$188.31	$339.7K
Dec 5, 2025	Sell	1,862	$184.87	$344.2K
May 9, 2025	Buy	1,500	$104.06	$156.1K
Mar 4, 2025	Sell	5,000	$115.03	$575.1K

Related Insiders

Andrew Reardon

officer: CLO & Secretary

LGNDSell · Apr 2, 2026

KOZARICH JOHN W

Director

LGNDSell · Apr 2, 2026

LAMATTINA JOHN L

Director

LGNDSell · Mar 31, 2026

Stephen L Sabba

director

LGNDSell · Mar 25, 2026

Andrew Reardon

CLO & Secretary

LGNZZSell · Feb 14, 2026

Todd C Davis

Chief Executive Officer

LGNZZSell · Feb 14, 2026

KOZARICH JOHN W

Director

LGNDZSell · Feb 2, 2026

Nancy Ryan Gray

Director

LGNDSell · Nov 12, 2025

Explore More Insider Trading Data

LGND Insider Trading Activity

View all insider trades at Ligand Pharmaceuticals Incorporated

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity